These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2429369)

  • 1. Rationale for chemotherapy for patients with advanced non-small-cell lung cancer.
    Greco FA
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):92-6. PubMed ID: 2429369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
    Honecker F; Wedding U; Bokemeyer C;
    Onkologie; 2004 Dec; 27(6):583-8. PubMed ID: 15591721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non-Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy.
    Goldman JW; Shi P; Reck M; Paz-Ares L; Koustenis A; Hurt KC
    Clin Lung Cancer; 2016 Jan; 17(1):80-4. PubMed ID: 26432508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triplet chemotherapy combinations with new agents: is there a rationale?
    Bunn PA
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients.
    Herbst RS
    Semin Oncol; 2003 Feb; 30(1 Suppl 1):30-8. PubMed ID: 12644982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options for elderly patients with advanced non-small cell lung cancer.
    Avery EJ; Kessinger A; Ganti AK
    Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative chemotherapy for non-small cell lung cancer.
    Adelstein DJ
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):35-9. PubMed ID: 7537902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative chemotherapy for advanced non-small cell lung cancer.
    Smith IE
    BMJ; 1994 Feb; 308(6926):429-30. PubMed ID: 7510189
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA
    Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.
    Kassam F; Shepherd FA; Johnston M; Visbal A; Feld R; Darling G; Keshavjee S; Pierre A; Waddell T; Leighl NB
    J Thorac Oncol; 2007 Jan; 2(1):39-43. PubMed ID: 17410008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of active treatment in non-small-cell lung cancer in elderly patients and patients with poor performance status.
    Lee D
    Clin Lung Cancer; 2003 Sep; 5(2):86-9. PubMed ID: 14596690
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.
    Haura EB
    Cancer Control; 2001; 8(4):326-36. PubMed ID: 11483886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer.
    Thongprasert S; Cheewakriangkrai R; Napapan S
    J Med Assoc Thai; 2002 Dec; 85(12):1296-300. PubMed ID: 12678167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy in lung carcinoma].
    Egger T; Cerny T
    Ther Umsch; 1994 Apr; 51(4):267-71. PubMed ID: 7514814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
    Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
    Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
    Chhajed PN; Baty F; Pless M; Somandin S; Tamm M; Brutsche MH
    Chest; 2006 Dec; 130(6):1803-7. PubMed ID: 17167000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of antiangiogenic therapy in non-small cell lung cancer.
    Giaccone G
    Clin Cancer Res; 2007 Apr; 13(7):1961-70. PubMed ID: 17404076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.